1. Águas, R., Mahdi, A., Shretta, R., Horby, P., Landray, M., White, L.,et al. (2021). Potential health and economic impacts of dexamethasone treatment for patients with COVID-19. Nat Commun, 12, 915. https://doi.org/10.1038/s41467-021-21134-2
  2. Douglas, N.M., Meumann, E.M., Krause, V.L. & Davies, J., for the Northern Territory COVID-19 Response Group (2020). Successful containment to date of SARS-CoV2 transmission in the Northern Territory.  The Medical Journal of Australia. doi: 10.5694/mja2.50840. 
  3. Davis, J.S., Ferreira, D., Denholm, J.T. & Tong, S.Y.C. (2020). Clinical trials for the prevention and treatment of coronavirus disease 2019 (COVID-19): The current state of play [Preprint]. The Medical Journal of Australia, April 27. 
  4. Howitt, R., Alves de Jesus, G., Araujo, F., Francis, J., Marr, I., McVean, M., MacMoran, E., Rollinson, V., Chung, A. & Yip, T.W. (2020). Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic. The Lancet Respiratory Medicine, April 22. doi: 10.1016/S2213-2600(20)30183-1.
  5. Hefler, M. & Gartner, C.E. (2020). The tobacco industry in the time of COVID-19: time to shut it down. Tobacco Control, 29, 245-246. doi: 10.1136/tobaccocontrol-2020-055807
  6. Kerrigan, V., Lee, A.M., Ralph, A.P., Lawton, P.D. (2020). Stay Strong: Aboriginal leaders deliver COVID-19 health messages. Health Promotion Journal of Australia. https://doi.org/10.1002/hpja.364
  7. Smith, J.A., & Judd.J. (2020). COVID-19: Vulnerability and the power of privilege in a pandemic. Health Promotion Journal of Australia, 31(2), 158-160. https://doi.org/10.1002/hpja.333